Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4A | P47712 | 1/20 | 0.42 |
| ▸ | CASP2 | P42575 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.41 |
| ▸ | FAAH | O00519 | 6/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22418273 | 0.96 | CASP2 (0.46) | PLA2G4ACASP2EPHX1FAAHZDHHC20 | |
| SCHEMBL24483714 | 0.92 | CASP2 (0.41) | CASP2EPHX1FAAHZDHHC20ZDHHC2 | |
| SCHEMBL24483720 | 0.92 | CASP2 (0.41) | CASP2EPHX1FAAHZDHHC20ZDHHC2 | |
| SCHEMBL22447142 | 0.88 | EPHX1 (0.50) | PLA2G4ACASP2EPHX1FAAHZDHHC20 | |
| SCHEMBL21076334 | 0.88 | EPHX1 (0.50) | PLA2G4ACASP2EPHX1FAAHZDHHC20 | |
| SCHEMBL19336122 | 0.88 | EPHX1 (0.50) | PLA2G4ACASP2EPHX1FAAHZDHHC20 | |
| SCHEMBL20903683 | 0.88 | EPHX1 (0.52) | PLA2G4ACASP2EPHX1FAAHZDHHC20 | |
| SCHEMBL24041036 | 0.88 | EPHX1 (0.52) | PLA2G4ACASP2EPHX1FAAHZDHHC20 | |
| SCHEMBL21527587 | 0.88 | EPHX1 (0.52) | PLA2G4ACASP2EPHX1FAAHZDHHC20 | |
| SCHEMBL18965287 | 0.88 | EPHX1 (0.52) | PLA2G4ACASP2EPHX1FAAHZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2934567-B1 | EXENDIN-4 DERIVATIVES AS DUAL GLP1/GIP- OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS | SANOFI SA (FR) | 2018-05-09 | — | — | EP | disclosed |
| EP-2934568-B1 | DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS | SANOFI SA (FR) | 2017-10-18 | — | — | EP | disclosed |
| EP-2934566-B1 | EXENDIN-4 DERIVATIVES AS DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS | SANOFI SA (FR) | 2017-06-21 | — | — | EP | disclosed |